News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Loretto Lacey, PhD

Articles by Loretto Lacey, PhD

The Cost-Effectiveness of Treatment with Lamivudine and Zidovudine Compared with Zidovudine Alone: A Comparison of Markov Model and Trial Data Estimates

ByJosephine Mauskopf, PhD,Loretto Lacey, PhD,Angela Kempel, PhD,Kit Simpson, DrPH

July 1st 1998

Latest Updated Articles

The Cost-Effectiveness of Treatment with Lamivudine and Zidovudine Compared with Zidovudine Alone: A Comparison of Markov Model and Trial Data Estimates
Published: July 1st 1998 | Updated:

Trending on AJMC

Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer

How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis

Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL

Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS

The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.